157 related articles for article (PubMed ID: 10369989)
1. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
Ongolo-Zogo P; Thiesse P; Sau J; Desuzinges C; Blay JY; Bonmartin A; Bochu M; Philip T
Eur Radiol; 1999; 9(5):907-14. PubMed ID: 10369989
[TBL] [Abstract][Full Text] [Related]
2. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
[TBL] [Abstract][Full Text] [Related]
3. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S
Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
[TBL] [Abstract][Full Text] [Related]
4. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Hanna SL; Parham DM; Fairclough DL; Meyer WH; Le AH; Fletcher BD
Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
6. Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma.
Edeline V; Frouin F; Bazin JP; Di Paola M; Kalifa C; Contesso G; Parmentier C; Lumbroso J; Di Paola R
Eur J Nucl Med; 1993 Dec; 20(12):1175-85. PubMed ID: 8299653
[TBL] [Abstract][Full Text] [Related]
7. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
[TBL] [Abstract][Full Text] [Related]
9. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
Shapeero LG; Henry-Amar M; Vanel D
Invest Radiol; 1992 Nov; 27(11):989-91. PubMed ID: 1464523
[No Abstract] [Full Text] [Related]
10. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Fletcher BD; Hanna SL; Fairclough DL; Gronemeyer SA
Radiology; 1992 Jul; 184(1):243-8. PubMed ID: 1319075
[TBL] [Abstract][Full Text] [Related]
11. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
[No Abstract] [Full Text] [Related]
12. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy.
Reddick WE; Bhargava R; Taylor JS; Meyer WH; Fletcher BD
J Magn Reson Imaging; 1995; 5(6):689-94. PubMed ID: 8748487
[TBL] [Abstract][Full Text] [Related]
13. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results.
Hanna SL; Reddick WE; Parham DM; Gronemeyer SA; Taylor JS; Fletcher BD
J Magn Reson Imaging; 1993; 3(6):849-53. PubMed ID: 8280973
[TBL] [Abstract][Full Text] [Related]
14. [Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Bielack S; Knop J; Delling G; Winkler K
Nuklearmedizin; 1988 Dec; 27(6):237-41. PubMed ID: 2464164
[TBL] [Abstract][Full Text] [Related]
15. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
[TBL] [Abstract][Full Text] [Related]
16. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.
Miwa S; Shirai T; Taki J; Sumiya H; Nishida H; Hayashi K; Takeuchi A; Ooi A; Tsuchiya H
Int J Clin Oncol; 2011 Aug; 16(4):373-8. PubMed ID: 21331769
[TBL] [Abstract][Full Text] [Related]
17. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
[TBL] [Abstract][Full Text] [Related]
18. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
Erlemann R; Sciuk J; Bosse A; Ritter J; Kusnierz-Glaz CR; Peters PE; Wuisman P
Radiology; 1990 Jun; 175(3):791-6. PubMed ID: 2188300
[TBL] [Abstract][Full Text] [Related]
19. Total body bone scan in the evaluation of tumor response to preoperative chemotherapy in the treatment of osteosarcoma.
Manfrini M; Rimondi E; Bruno A; Capanna R; Albisinni U; Picci P; Bacci G; Gaiani L; Tarozzi C
Chir Organi Mov; 1990; 75(4):325-30. PubMed ID: 2098218
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]